Issue link: https://viewer.e-digitaledition.com/i/1305733
COVER STORY REASSESSING MANDATORY MASTECTOMY RECOMMENDATIONS 10 New guidelines published in the Journal of Clinical Oncology could mean less women with BRCA1 and BRCA2 mutations would need to have preventative double mastectomies. Factors to be considered include the ability to get an annua l breast MRI and receive chemotherapy. Breast-conserving therapy will be given as an option if appropriate. CLINICAL DISCUSSIONS LEUKEMIA DRUGS FOR LUNG CANCER? 05 A new study shows that two leukemia treatment drugs show potentia l for treating patients who have lung cancer with triple mutant epiderma l grow th factor receptor. The new drugs could possibly offset drug resistance currently happening in about ha lf of patients who are treated with second-generation inhibitors. NEW DEVELOPMENTS IN TYPE 1 DIABETES PREVENTION 18 New studies are finding that there are possible ways to prevent and manage Type 1 diabetes, a disease that affects 1.6 million people. Teplizumab, an anti-CD3 monoclona l antibody, could delay a diagnosis, while the drug golimumab could preserve beta-cell function and reduce the amount of insulin injections needed. contents /////// OCT/NOV 2020 SPECIAL FE ATURES IMPROVING PATIENT MEDICATION ADHERENCE BY PROVIDING AN ALTERNATIVE TO EYE DROPS 08 Glaucoma is a chronic condition that can cause irreversible vision loss if untreated. Typica lly, elevated intraocular pressure will damage the optic nerve a xons and cause permanent periphera l vision loss followed by centra l vision loss. Grene Vision Group offers solutions. DEDICATED HOSPITALIST MODEL, TEAMWORK A DIFFERENTIATOR FOR ASCENSION VIA CHRISTI CANCER INSTITUTE 12 Ascension Via Christi is the only hospita l in Kansas outside of the Kansas City metro area with an inpatient cancer treatment center staffed seven days a week with board- certified internists dedicated to cancer care. ASCENSION VIA CHRISTI CANCER CENTER NOW TREATING PATIENTS WITH LATEST GENERATION CYBERKNIFE 13 Since the Ascension Via Christi CyberKnife Center opened its doors in 2006, the clinica l team has used the system to provide highly precise, nonsurgica l and noninvasive treatment to more than 4,000 patients with cancerous tumors and benign lesions. DEPARTMENTS HOSPITAL ROUNDS 06, 07, 15, 16, 17 MEDICAL REAL ESTATE 15 INNOVATION + TECHNOLOGY 19 10 ON THE COVER 08 13